Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational

Ruth Nussinov1,2, Hyunbum Jang1, Chung-Jung Tsai1

  • 1Computational Structural Biology Section, Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.

Insights

Precision oncology uses genomic data to tailor cancer treatments. This review integrates precision pharmacology, examining protein structures and signaling pathways for improved therapeutic strategies.

Area of Science:

  • Oncology
  • Genomics
  • Pharmacology

Background:

  • Precision medicine and oncology aim to improve cancer treatment by aligning therapies with a patient's tumor genomic alterations.
  • Major initiatives involve whole-genome sequencing, large databases, and statistical analysis to identify actionable alterations and molecular targets.

Purpose of the Study:

  • To provide a comprehensive review of precision oncology, uniquely incorporating precision pharmacology.
  • To articulate the protein structural landscape and its impact on cellular signaling pathways within the precision pharmacology framework.

Main Methods:

  • Review of existing literature on precision oncology, genomic sequencing, and statistical analysis of cancer data.
  • Integration of principles from structural biology and pharmacology to analyze protein alterations and their functional consequences.
  • Exploration of the physicochemical basis of molecular interactions in cancer signaling.

Main Results:

  • Statistical analysis of genomic data is crucial but may not fully capture the functional impact of mutations, especially rare ones, by not identifying protein conformational changes.
  • Precision pharmacology offers a deeper understanding by considering the structural and functional consequences of genomic alterations on cellular pathways.
  • The review highlights the importance of understanding protein structure and signaling for identifying effective, actionable mutations.

Conclusions:

  • Integrating precision pharmacology with precision oncology provides a more complete picture of cancer biology and treatment strategies.
  • Understanding the protein structural landscape and its effects on cellular signaling is essential for advancing precision cancer therapy.
  • This approach offers a physicochemical basis for interpreting genomic data, potentially improving the identification of rare but actionable mutations.

Related Concept Videos

Conformity01:20

Conformity

Conformity is the change in a person’s behavior to go along with the group, even if that person does not agree with the group.
47.9K
Mutations01:39

Mutations

Overview
94.5K
Hardy-Weinberg Principle01:49

Hardy-Weinberg Principle

Diploid organisms have two alleles of each gene, one from each parent, in their somatic cells. Therefore, each individual contributes two alleles to the gene pool of the population. The gene pool of a population is the sum of every allele of all genes within that population and has some degree of variation. Genetic variation is typically expressed as a relative frequency, which is the percentage of the total population that has a given allele, genotype or phenotype.
76.1K
The Uncertainty Principle04:08

The Uncertainty Principle

Werner Heisenberg considered the limits of how accurately one can measure properties of an electron or other microscopic particles. He determined that there is a fundamental limit to how accurately one can measure both a particle’s position and its momentum simultaneously. The more accurate the measurement of the momentum of a particle is known, the less accurate the position at that time is known and vice versa. This is what is now called the Heisenberg uncertainty principle. He...
31.5K
Empirical Method to Interpret Standard Deviation01:09

Empirical Method to Interpret Standard Deviation

The empirical rule, also known as the three-sigma rule, allows a statistician to interpret the standard deviation in a normally distributed dataset. The rule states that 68% of the data lies within one standard deviation from the mean, 95% lies within two standard deviations from the mean, and 99.7% lies within three standard deviations from the mean. Additionally, this rule is also called the 68-95-99.7 rule.
This rule is used widely in statistics to calculate the proportion of data values...
9.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.7K